Literature DB >> 24944235

Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.

Vincent Lo Re1, Li Wang2, Scott Devine3, Onur Baser4, Temitope Olufade3.   

Abstract

The incidence rate of hepatic decompensation was higher in patients with human immunodeficiency virus (HIV)/hepatitis B virus (HBV)/hepatitis C virus (HCV) triple infection than in those with HIV/HCV coinfection (24.1 vs 10.8 events per 1000 person-years; hazard ratio [HR], 1.89; 95% confidence interval [CI], 1.12-3.18). Compared with HIV/HCV-infected patients, the rate of decompensation was increased among HIV/HBV/HCV-infected patients receiving no anti-HBV therapy (HR, 2.48; 95% CI, 1.37-4.49) but not among those who did receive such therapy (HR, 1.09; 95% CI, .40-2.97).
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; end-stage liver disease; hepatic decompensation; hepatitis B; hepatitis C

Mesh：

Substances：

Year:  2014        PMID： 24944235      PMCID： PMC6284256          DOI： 10.1093/cid/ciu476

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  23 in total

1.  Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues.

Authors:  Luz Martín-Carbonero; Tiago Teixeira; Eva Poveda; Zulema Plaza; Eugenia Vispo; Juan González-Lahoz; Vincent Soriano
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

2.  Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.

Authors:  Berkeley N Limketkai; Shruti H Mehta; Catherine G Sutcliffe; Yvonne M Higgins; Michael S Torbenson; Sherilyn C Brinkley; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

3.  Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.

Authors:  Vincent Soriano; Pablo Barreiro; Luz Martín-Carbonero; Carol Castellares; Andres Ruiz-Sancho; Pablo Labarga; Belen Ramos; Juan Gonzalez-Lahoz
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

4.  Development and verification of a "virtual" cohort using the National VA Health Information System.

Authors:  Shawn L Fultz; Melissa Skanderson; Larry A Mole; Neel Gandhi; Kendall Bryant; Stephen Crystal; Amy C Justice
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

5.  Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.

Authors:  Giulia Morsica; Sabrina Bagaglio; Paola Cicconi; Maria R Capobianchi; Giampietro Pellizzer; Pietro Caramello; Anna Orani; Cristina Moioli; Giuliano Rizzardini; Caterina Uberti-Foppa; Massimo Puoti; Antonella D'Arminio Monforte
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

6.  Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study.

Authors:  Amy C Justice; Kathleen A McGinnis; J Hampton Atkinson; Robert K Heaton; Corinna Young; Joseph Sadek; Tamra Madenwald; James T Becker; Joseph Conigliaro; Sheldon T Brown; David Rimland; Steve Crystal; Michael Simberkoff
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

7.  Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.

Authors:  Adeel A Butt; Shawn L Fultz; C Kent Kwoh; David Kelley; Melissa Skanderson; Amy C Justice
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

8.  Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.

Authors:  Vincent Lo Re; Michael J Kallan; Janet P Tate; A Russell Localio; Joseph K Lim; Matthew Bidwell Goetz; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Lesley Park; Robert Dubrow; K Rajender Reddy; Jay R Kostman; Brian L Strom; Amy C Justice
Journal:  Ann Intern Med       Date:  2014-03-18       Impact factor: 25.391

9.  Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.

Authors:  A Boyd; K Lacombe; P Miailhes; J Gozlan; P Bonnard; J-M Molina; C Lascoux-Combe; L Serfaty; E Gault; M Desvarieux; P-M Girard
Journal:  J Viral Hepat       Date:  2009-08-04       Impact factor: 3.728

10.  Prevalence of diagnosed chronic hepatitis B infection among U.S. Medicaid enrollees, 2000-2007.

Authors:  Dana D Byrne; Craig W Newcomb; Dena M Carbonari; Melissa S Nezamzadeh; Kimberly B F Leidl; Maximilian Herlim; Yu-Xiao Yang; Sean Hennessy; Jay R Kostman; Mary B Leonard; Russell Localio; Vincent Lo Re
Journal:  Ann Epidemiol       Date:  2014-03-05       Impact factor: 3.797
View more
  6 in total

Review 1.  Viral hepatitis and human immunodeficiency virus co-infections in Asia.

Authors:  Takako Utsumi; Maria I Lusida
Journal:  World J Virol       Date:  2015-05-12

2.  Prevalence of Hepatocellular Carcinoma in HIV Patients Co-infected or Triple Infected With Hepatitis B and Hepatitis C in a Community Hospital in South Bronx.

Authors:  Shehriyar Mehershanhi; Asim Haider; Sameer Kandhi; Haozhe Sun; Harish Patel
Journal:  Cureus       Date:  2022-06-19

Review 3.  Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.

Authors:  David L Wyles; Mark S Sulkowski; Douglas Dieterich
Journal:  Clin Infect Dis       Date:  2016-07-15       Impact factor: 9.079

4.  Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.

Authors:  Marina B Klein; Keri N Althoff; Yuezhou Jing; Bryan Lau; Mari Kitahata; Vincent Lo Re; Gregory D Kirk; Mark Hull; H Nina Kim; Giada Sebastiani; Erica E M Moodie; Michael J Silverberg; Timothy R Sterling; Jennifer E Thorne; Angela Cescon; Sonia Napravnik; Joe Eron; M John Gill; Amy Justice; Marion G Peters; James J Goedert; Angel Mayor; Chloe L Thio; Edward R Cachay; Richard Moore
Journal:  Clin Infect Dis       Date:  2016-08-09       Impact factor: 9.079

5.  Human immunodeficiency virus and liver disease: A comprehensive update.

Authors:  Kenneth E Sherman; Marion G Peters; David Thomas
Journal:  Hepatol Commun       Date:  2017-11-06

6.  Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.

Authors:  Jing Sun; Keri N Althoff; Yuezhou Jing; Michael A Horberg; Kate Buchacz; M John Gill; Amy C Justice; Charles S Rabkin; James J Goedert; Keith Sigel; Edward Cachay; Lesley Park; Joseph K Lim; H Nina Kim; Vincent Lo Re; Richard Moore; Timothy Sterling; Marion G Peters; Chad J Achenbach; Michael Silverberg; Jennifer E Thorne; Angel M Mayor; Heidi M Crane; Mari M Kitahata; Marina Klein; Gregory D Kirk
Journal:  JAMA Netw Open       Date:  2021-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.